Press release
AI In Oncology Market CAGR to Exceed 14%, Due to The Growing Demand for Diagnosis of Cancer Indications | Roots Analysis
With an aim to counter the rising number of cancer cases across the globe, artificial intelligence has emerged as the key enabler in cancer treatment to generate better clinical outcomes.According to the World Health Organization (WHO), in the healthcare sector, oncology is one of the important sections primarily because cancer is the second leading causes of mortality worldwide. It is estimated that in 2022, about 1.9 million new cancer cases and 609,360 deaths are expected to occur in the US. Further, estimates indicate that over the next decade, around 21.4 million new patients are likely to be diagnosed with cancer each year. With an aim to counter the rising number of cancer cases across the globe, AI has emerged as the key enabler in cancer treatment to improve detection accuracy, speed, assist clinical decision-making and result in better clinical outcomes
To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/ai-in-oncology-market/request-quote.html
The AI in oncology market is estimated to grow from USD 1.7 billion in 2024 to reach USD 2.4 billion in 2025 and USD 9.1 billion by 2035, representing a higher CAGR of 14.1% during the forecast period.
The most successful examples include the detection of precancerous lesions, where treatment reduces the risk of malignant tumors. An AI system can aid in the reduction of diagnostic and treatment errors that are unavoidable in human clinical practice this may reduce testing costs and avoid wasteful therapy-related expenditures. Given the various advantages and technological advancements in the field of AI and its extensive utilization in oncology, stakeholders in this domain are integrating it in their regular workflow.
The current ai in oncology market landscape features the presence of over 76 players that are engaged in offering AI in oncology-based software solutions; of these, most of the players (39%) engaged in this domain were established between 2011-2015. Notable examples are (in alphabetical order) b-rayZ, ConcertAI. Further, the AI in oncology market is currently dominated by the presence of small players (51%). Notable examples of well-established players engaged in this domain include (in alphabetical order) ConcertAI and DeepMind. In fact, most of the service providers are presently headquartered in North America (41%). Further, within Europe, the UK emerged as the prominent base of operations for the players located in the aforementioned region. It is worth mentioning that all the companies engaged in this domain offer AI in oncology-based software solutions to hospitals (52%), followed by those (17%) providing such software solutions to non-industry players (such as research institutes).
To request a sample copy / brochure of this report, please visit:
https://www.rootsanalysis.com/reports/ai-in-oncology-market/request-sample.html
Majority of these service providers are offering AI in oncology-based software solutions for cancer detection (92%) followed by drug development and drug discovery services. Followed by the type of AI technology being used for the service(s) being offered , machine learning is being incorporated by 46% of the service providers followed by deep learning (26%).
The growing pipeline and the increasing demand for effective diagnosis of cancer indications at an early stage using AI to prevent malignacies, has spurred the establishment of many companies in the last decades. Stakeholders claim to offer various AI powered service(s) ; about 26% players have the required capabilities to utilize both machine learning and deep learning. Majority of the companies engaged in this domain offer services to hospitals via its technology; these platforms can be deployed on site or on cloud. It is worth noting 67% of these are deployed on cloud. Moreover, as can be observed in the figure, currently, AI in diagnostics market is dominated by companies based in North America, majority of them being small-sized.
Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/ai-in-oncology-market.html
Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI In Oncology Market CAGR to Exceed 14%, Due to The Growing Demand for Diagnosis of Cancer Indications | Roots Analysis here
News-ID: 4212219 • Views: …
More Releases from Roots Analysis
Gene switches have garnered significant attention from drug developers owing to …
The global gene switch market size is estimated to grow from USD 795 million in 2025 to USD 2,478 million by 2035, representing a CAGR of 12.03% during the forecast period till 2035.
Driven by numerous developmental breakthroughs and encouraging study results demonstrating the vast potential of adoptive cell therapies (ACT), including CAR-T cell therapies, TCR therapies, TILs and natural killer cell therapies, in the treatment of various complex disorders, this…
Antibody Discovery Market Set to Soar to $6.6 Billion by 2035
Antibodies, also known as immunoglobulins, are Y-shaped glycoproteins that are produced by the immune system in response to foreign molecules (antigens) that enter the body. The term antigen refers to any substance that is capable of inducing an immune response, encompassing a diverse range of entities, including viruses, fungi, bacteria, proteins on the surface of cells, and non-living substances, such as toxins, chemicals and foreign particles.
The global antibody discovery…
Biopsy is defined as a procedure of removing or extracting tissue from the body …
The global virtual biopsy market, valued at USD 0.73 billion in 2024, is projected to reach USD 0.78 billion in 2025 and USD 3.02 billion by 2035, representing a CAGR of 14.47% during the forecast period.
This procedure plays a crucial role in the diagnosis or monitoring of certain medical conditions such as inflammatory disorders, immune disorders, oncological conditions, and several infections. By analyzing the cellular composition of the extracted tissue,…
Big data in healthcare: transforms patient care, enhances efficiency, and unlock …
The global big data in healthcare market size is estimated to grow from USD 78 billion in 2024 to USD 540 billion by 2035, representing a CAGR of 19.20% during the forecast period till 2035. Big data in healthcare is the collection of large amounts of unstructured data from various sources, such as medical research, biometric data, electronic medical records, Internet of Medical Things (IoMT), social media, payer records, omics…
More Releases for CAGR
[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064
According to the report published by Allied Market Research,…
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032.
This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks…
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic…
Waterproofing Membranes Market is Projected Grow at CAGR of 8% CAGR by 2033
The waterproofing membranes market is anticipated to witness a Compound Annual Growth Rate (CAGR) of 8.0% over the forecast period. By 2023, the estimated market value for waterproofing membranes is substantial, reaching US$ 31.5 billion.
These waterproofing materials comprise thin, impermeable membranes designed to collaborate with asphalt, providing a protective shield for the structural integrity of buildings. The asphalt component in these membranes acts as a safeguard, preserving the underlying membrane…
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research
A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial…
Pediatric Radiology Market Size will Grow at CAGR 7.7% CAGR during 2017-2026
Pediatric Radiology Market:Overview
The pediatric radiology market is likely to register robust growth in the near future. Chronic illnesses among children including neurological disorders such as ADHD are on the rise. According to the US labor bureau, the demand for pediatrician is expected to grow by 24% on average by 2020. This is the highest average growth among all professionals in the United States.
Despite challenges such as training for new…
